Ocular therapeutix™ reports second quarter 2020 financial results and business update

Ocular therapeutix™, inc. (nasdaq: ocul), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative the

CAH Ratings Summary

CAH Quant Ranking